WELLS FARGO & COMPANY/MN - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 45 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2023$3,593,787
+21.0%
3,701,500
+22.9%
0.00%0.0%
Q2 2023$2,971,018
-7.8%
3,012,500
-4.0%
0.00%0.0%
Q1 2023$3,222,934
-4.1%
3,137,500
-0.7%
0.00%0.0%
Q4 2022$3,359,528
+3.6%
3,159,500
-3.0%
0.00%0.0%
Q3 2022$3,243,000
-0.6%
3,257,500
-1.2%
0.00%0.0%
Q2 2022$3,262,000
-23.4%
3,295,500
-22.1%
0.00%0.0%
Q1 2022$4,260,000
+36.7%
4,231,500
+42.0%
0.00%0.0%
Q4 2021$3,117,000
-1.3%
2,980,500
-3.4%
0.00%0.0%
Q3 2021$3,158,000
-0.2%
3,086,500
+1.0%
0.00%0.0%
Q2 2021$3,165,000
-15.4%
3,054,500
-17.4%
0.00%0.0%
Q1 2021$3,743,000
-10.9%
3,699,500
-5.5%
0.00%0.0%
Q4 2020$4,200,000
+100.2%
3,914,500
+95.8%
0.00%0.0%
Q3 2020$2,098,000
-19.9%
1,999,000
-6.7%
0.00%0.0%
Q2 2020$2,618,000
+13.3%
2,142,000
-2.8%
0.00%0.0%
Q1 2020$2,310,000
-8.0%
2,204,000
-7.2%
0.00%0.0%
Q4 2019$2,511,000
+3.2%
2,376,000
-4.0%
0.00%0.0%
Q3 2019$2,434,000
-8.8%
2,476,000
-3.7%
0.00%0.0%
Q2 2019$2,668,000
-3.2%
2,570,000
-4.6%
0.00%0.0%
Q1 2019$2,756,000
-26.7%
2,694,000
-28.8%
0.00%0.0%
Q4 2018$3,761,000
+27.4%
3,782,000
+36.5%
0.00%0.0%
Q3 2018$2,952,000
+31.8%
2,770,000
+17.1%
0.00%0.0%
Q1 2018$2,239,000
-59.4%
2,365,000
-57.1%
0.00%
-50.0%
Q4 2017$5,520,000
-51.9%
5,513,000
-51.0%
0.00%
-50.0%
Q3 2017$11,467,00011,250,0000.00%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q2 2021
NameSharesValueWeighting ↓
Wellesley Asset Management 53,670$57,726,0003.34%
SHENKMAN CAPITAL MANAGEMENT INC 26,959,000$29,149,0003.04%
ADVENT CAPITAL MANAGEMENT /DE/ 84,134,000$90,539,0001.93%
Cheyne Capital Management (UK) LLP 3,220,000$3,452,0001.75%
PFM Health Sciences, LP 40,300,000$43,210,0001.52%
Sonora Investment Management, LLC 6,370,000$6,807,0000.56%
MACKAY SHIELDS LLC 66,018,000$70,980,0000.49%
ZAZOVE ASSOCIATES LLC 1,500,000$1,608,0000.20%
IRON Financial LLC 275,000$295,0000.15%
PALISADE CAPITAL MANAGEMENT, LP 3,000,000$3,216,0000.08%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders